SUBMIT YOUR BUZZ TODAY! You are not signed in (Sign In or Register)


Tuesday, January 25, 2011 / Value Companies


CLIFTON, N.J. – Some of the nation’s most recognizable and respected apartment owners joined together during National Breast Cancer Awareness month last October to raise more than $25,000 for the Cure Breast Cancer Foundation (CBCF), a non-profit 501 (c) 3 organization which supports breast cancer research efforts of Dr. Larry Norton Deputy Physician-in-Chief for Breast Cancer Programs and the Medical Director of the Evelyn H. Lauder Breast Center at the Memorial Sloan-Kettering Cancer Center.

More than 15 companies took part in the 1st Annual Apartment Owners Lease for a Cure initiative in which a donation of $10 was given to the CBCF for every new lease signed at their rental communities in October.  Participating apartment owners and managers included Value Companies, Affiliated Management, AvalonBay Communities, Bertram Associates, BNE Associates, CJ Lombardo, Gibbs Family Properties, Goldberg Realty, JK Management LLC, KRE Group, Kriegman & Smith, Inc., Pen Realty LLC, Quaker Group, Roseland Properties, Segal & Segal, Solomon Management LLC and Sterling Properties.

“To say the 1st Annual Apartment Owners Lease for a Cure initiative was a success would be a vast understatement,” says Andrew Abramson, secretary of CBCF.  “We are extremely grateful to each and every apartment owner who participated and supported the foundation and breast cancer research.  This is a perfect example of how a corporate community can come together to assist a very worthy cause, and we are looking forward to even greater participation and more success next year.  Their generosity will help take the work of Dr. Norton to the next level.”

Dr. Norton's research focuses on the theory of breast cancer “self seeding”: the ability of breast cancer cells to move and start new cancers growing, not only in distant organs like the bones and liver (called metastases), but in the breast itself.  This behavior is referred to as “self seeding” as it recalls the way weeds take over a garden: not by the growth of each individual weed plant, but by the seeding of new weed plants that grow in a confluent fashion.  By this concept, breast cancer is not one mass, but rather a collection of contiguous smaller masses.

This method of growth is indeed true in certain experimental models and research is ongoing to prove that it happens in people as well.  It explains many aspects of cancer: rapid growth, disorganization, formation of new blood vessels, need to irradiate a breast after a lumpectomy for cancer and the association of all of the above with distant metastases.  If correct, it will provide new targets for the development of drugs to treat and prevent cancer.  Since “seeding” is an abnormal process—as opposed to the normal process of mitosis—such drugs may not only be more effective, but less toxic as well.  Hence, the concept of self-seeding is not only interesting from the point of view of biology, but possibly very important in the design of better approaches to cancer management and prevention, as well as in finding a cure.

Since its inception, CBCF has raised in excess of $1.8 million through events such as the annual golf tournament, walk-a-thons and other fundraising events.  Fully 100% of its net fundraising proceeds received by the foundation are donated to the Memorial Sloan-Kettering Cancer Center in Manhattan and other research facilities to support the ground-breaking research being conducted by noted oncologist Dr. Larry Norton and his colleagues.  

Cure Breast Cancer Foundation
The Cure Breast Cancer Foundation (CBCF), is a Clifton, N.J. –based not-for-profit 501(c) 3 charity devoted to fund breast cancer research on the growth and spreading of breast cancer cells, also known as self seeding, under the direction of Dr. Larry Norton and his colleagues.

The founder and president is Carly Abramson.  Her father, Andrew Abramson, is secretary.  Leslye Schulman is Executive Director.  For more information, call (973) 471-CBCF (2223), e-mail or visit the Web site at

Published by : George Cahn
George M. Cahn
CAHN Communications This article has been viewed 1489 time(s).

Related Articles :
No Related Content Found

Share this article on LinkedIn

Report this article as abuse

Reviews : 0
User Rating :

Submit your Review